Although new microgrid configurations, technologies, and business models are still evolving in the U.S., some lessons have been learned in the past few years. Aside ...
Identifying and accelerating drug development is big business. The costs in this industry are significant and finding pathways to optimize using AI methods is top of mind in this fast and evolving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results